Global lung injury market size was valued at $1.5 billion in 2020 and is projected to reach $2.4 billion by 2030 registering a CAGR of 4.20% from 2021 to 2030. Lung injury is commonly characterized by hypoxia, lung complication, and pulmonary edema. This condition causes inflammation or direct injury to the lungs. Symptoms include severe shortness of breath, low blood pressure, confusion and extreme tiredness. Acute lung injury (ALI) is a multi-factorial process, the onset of which is triggered by environmental factors among genetically predisposed individuals. Although ALI-inducing events are common, only a fraction of those exposed develop the syndrome. Environmental triggers for developing ALI can be divided into those causing direct and those causing indirect lung injury, with sepsis, either intrapulmonary or extrapulmonary being the commonest cause.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/13445
๐๐ผ๐๐ถ๐ฑ-๐ญ๐ต ๐ฆ๐ฐ๐ฒ๐ป๐ฎ๐ฟ๐ถ๐ผ:
Acute lung injury represents the most severe form of the viral infection sustained by COVIDโ19. Incidence and severity of acute lung injury are a key determining factor of the prognosis of patients with COVIDโ19 infection. Around 30% of patients with COVIDโ19 infection in the ICU diagnosed with severe lung edema, dyspnea, hypoxemia, or even acute respiratory distress syndrome. Hence, the overall impact of COVID-19 pandemic remained positive, as COVID-19 has direct relation with acute lung injury, and hence boosted the use of therapies and devices, which is likely to drive the growth of the lung injury market.
๐
๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/13445
The global lung injury market is segmented into therapy, end user, and region. Depending on therapy, the market is bifurcated into medication and device. The medication segment is further categorized into pharmacotherapy, fluid management, and inhaled nitric oxide. Moreover, the devices is subdivided into mechanical ventilation and adjunctive procedures devices.
On the basis of injury type, the market is classified into direct injury and indirect injury. By end user, it is fragmented into hospitals & clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
On the basis of therapy, the medication segment was the major shareholder 2020, as various therapies were used as supportive treatment for lung injury.
Depending on injury type, the direct injury acquired the largest share in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to rise in incidence of pulmonary infections worldwide.
๐๐๐ ๐
๐๐๐๐๐๐๐ ๐๐
๐๐๐ ๐๐๐๐๐
- By therapy, the medication segment garnered the largest share in the global market in 2020.
- On the basis of injury type, the direct injury was the major shareholder in 2020, and expected to remain dominant throughout the forecast period.
- Depending on end user, the hospitals & clinics dominated the global market in 2020, and is anticipated to continue this trend during the forecast period.
- Region wise, Asia-Pacific is expected to exhibit highest CAGR of 5.50% during the forecast period.ย
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
ย